SCHEMBL17849092

SCHEMBL17849092

Brc1ccc2cc3cc4cc5ccc(Br)cc5cc4cc3cc2c1

nearest known ligand 0.68

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP2A6 P11509 3/20 0.68
KDM4E B2RXH2 1/20 0.62
MEN1 O00255 1/20 0.62
ALDH1A1 P00352 1/20 0.62
MAPT P10636 1/20 0.62
KMT2A Q03164 1/20 0.62
BACE1 P56817 2/20 0.46
AHR P35869 3/20 0.44
NR4A2 P43354 1/20 0.44
CYP11B1 P15538 1/20 0.43
CYP11B2 P19099 1/20 0.43
NCEH1 Q6PIU2 1/20 0.42
NOS1 P29475 2/20 0.41
METAP2 P50579 2/20 0.41
CYP1A2 P05177 1/20 0.41
CYP2C19 P33261 1/20 0.41
HTT P42858 1/20 0.41
CSNK2A1 P68400 1/20 0.41
DYRK1A Q13627 1/20 0.41
ALOX15 P16050 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23312077 1.00 CYP2A6 (0.68) CYP2A6KDM4EMEN1ALDH1A1MAPT
SCHEMBL17849089 1.00 CYP2A6 (0.68) CYP2A6KDM4EMEN1ALDH1A1MAPT
SCHEMBL148642 1.00 CYP2A6 (0.68) CYP2A6KDM4EMEN1ALDH1A1MAPT
SCHEMBL29427549 1.00 CYP2A6 (0.68) CYP2A6KDM4EMEN1ALDH1A1MAPT
SCHEMBL13153611 1.00 CYP2A6 (0.68) CYP2A6KDM4EMEN1ALDH1A1MAPT
SCHEMBL29353067 0.93 CYP2A6 (0.77) CYP2A6KDM4EMEN1ALDH1A1MAPT
SCHEMBL192166 0.93 CYP2A6 (0.77) CYP2A6KDM4EMEN1ALDH1A1MAPT
SCHEMBL4585492 0.91 CYP2A6 (0.84) CYP2A6KDM4EMEN1ALDH1A1MAPT
SCHEMBL1304424 0.91 CYP2A6 (0.84) CYP2A6KDM4EMEN1ALDH1A1MAPT
SCHEMBL17849081 0.91 CYP2A6 (0.84) CYP2A6KDM4EMEN1ALDH1A1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10752730-B2 Quantitative intramolecular fission in oligoacenes, materials, and methods of use thereof THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK (US) 2020-08-25 US disclosed
US-20180258217-A1 QUANTITATIVE INTRAMOLECULAR FISSION IN OLIGOACENES, MATERIALS, AND METHODS OF USE THEREOF UNITED STATES DEPARTMENT OF ENERGY 2018-09-13 US disclosed
WO-2016100754-A1 QUANTITATIVE INTRAMOLECULAR FISSION IN OLIGOACENES, MATERIALS, AND METHODS OF USE THEREOF THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK (US) 2016-06-23 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10752730-B2 Quantitative intramolecular fission in oligoacenes, materials, and methods of use thereof SPIN1, SPIN3, ESPL1 CYP2A6 4774/4885KDM4E 4485/4885MEN1 2754/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.